Influence of renin–angiotensin system blockades on vascular access survival in patients on maintenance hemodialysis
Seminars in Dialysis · 2024
DOI: 10.1111/sdi.13189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Seminars in Dialysis, 2024. Verfasst von Seok Hui Kang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu, Republic of Korea. Hauptthemen laut MEDLINE: Renal Dialysis, Antihypertensive Agents, Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Antagonists. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Ministry of Science, ICT, and Future Planning, Ministry of Education, Korea government (MSIT).
Abstract (Originalsprache)
Introduction
Results on the association between the use of renin–angiotensin system blockades (RASBs) and vascular access‐related outcomes are inconsistent. We aimed to compare vascular access‐related outcomes according to the use of RASBs in hemodialysis patients.
Methods
This study used data from a national hemodialysis quality assessment program of the Republic of Korea ( n = 54,903). Group 1 was not prescribed any blood pressure‐lowering drugs ( n = 28,521). Group 2 was prescribed other blood pressure‐lowering agents except for RASBs ( n = 9571). Group 3 was prescribed RASBs ( n = 16,811). Vascular access‐related outcomes were classified into intervention‐free survival (IFS), thrombosis‐free survival (TFS), and vascular access survival (VAS).
Results
No significant difference in the three access survival rates was identified among the three groups. The multivariate Cox regression analyses indicated that Group 3 had better outcomes in IFS and TFS than Group 1. The numbers of angioplasties performed were significantly greater in Group 1 than in the other two groups. The numbers of thrombectomies performed were significantly the lowest in Group 3 among all the groups.
Conclusions
Our study revealed different results according to types of access survival in univariate or multivariate analyses. The association of RASBs with favorable outcomes in vascular access remains unclear.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu, Republic of Korea.
- Healthcare Review and Assessment Committee, Health Insurance Review and Assessment Service, Wonju, Republic of Korea.
- Quality Assessment Department, Health Insurance Review and Assessment Service, Wonju, Republic of Korea.
ORCID-Profile: Seok Hui Kang
Förderung
- Ministry of Science, ICT, and Future Planning
- Ministry of Education
- Korea government (MSIT)
- Ministry of Science, ICT and Future Planning
Zitieren
APA
Kang, S. H., Kim, B. Y., Son, E. J., Kim, G. O., & Do, J. Y. (2024). Influence of renin–angiotensin system blockades on vascular access survival in patients on maintenance hemodialysis. Seminars in Dialysis. https://doi.org/10.1111/sdi.13189
Vancouver
Kang SH, Kim BY, Son EJ, Kim GO, Do JY. Influence of renin–angiotensin system blockades on vascular access survival in patients on maintenance hemodialysis. Seminars in Dialysis. 2024. doi:10.1111/sdi.13189
BibTeX
@article{Kang2024,
author = {Kang, Seok Hui and Kim, Bo Yeon and Son, Eun Jung and Kim, Gui Ok and Do, Jun Young},
title = {Influence of renin–angiotensin system blockades on vascular access survival in patients on maintenance hemodialysis},
journal = {Seminars in Dialysis},
year = {2024},
doi = {10.1111/sdi.13189}
}
EUVIMED